Modeling Psychomotor Retardation using iPSCs from MCT8-Deficient Patients Indicates a Prominent Role for the Blood-Brain Barrier

Cell Stem Cell
Gad D VatineClive N Svendsen

Abstract

Inactivating mutations in the thyroid hormone (TH) transporter Monocarboxylate transporter 8 (MCT8) cause severe psychomotor retardation in children. Animal models do not reflect the biology of the human disease. Using patient-specific induced pluripotent stem cells (iPSCs), we generated MCT8-deficient neural cells that showed normal TH-dependent neuronal properties and maturation. However, the blood-brain barrier (BBB) controls TH entry into the brain, and reduced TH availability to neural cells could instead underlie the diseased phenotype. To test potential BBB involvement, we generated an iPSC-based BBB model of MCT8 deficiency, and we found that MCT8 was necessary for polarized influx of the active form of TH across the BBB. We also found that a candidate drug did not appreciably cross the mutant BBB. Our results therefore clarify the underlying physiological basis of this disorder, and they suggest that circumventing the diseased BBB to deliver active TH to the brain could be a viable therapeutic strategy.

Citations

Mar 29, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Abraham J Al-AhmadEric V Shusta
Dec 8, 2017·Journal of Biological Engineering·John J JamiesonSharon Gerecht
Jun 19, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Brian ChiouJames R Connor
May 31, 2018·Thyroid : Official Journal of the American Thyroid Association·Soledad Bárez-LópezAna Guadaño-Ferraz
Oct 4, 2018·Physiological Reviews·Melanie D SweeneyBerislav V Zlokovic
Feb 16, 2018·Clinical Science·Isobel ParkesM Zameel Cader
Jul 31, 2019·Thyroid : Official Journal of the American Thyroid Association·Soledad Bárez-LópezAna Guadaño-Ferraz
Aug 7, 2019·Expert Opinion on Drug Discovery·Lino Ferreira
May 24, 2019·Acta Physiologica·Jean-David GothiéSylvie Remaud
Dec 5, 2019·Thyroid : Official Journal of the American Thyroid Association·Inbal AdmatiLior Appelbaum
Nov 23, 2019·Endocrine Reviews·Stefan GroenewegW Edward Visser
Aug 23, 2019·Fluids and Barriers of the CNS·Brandon J KimEric V Shusta
Jul 21, 2020·PloS One·Carmen Grijota-MartínezAna Guadaño-Ferraz
Mar 27, 2020·The Journal of Experimental Medicine·Caterina P ProfaciRichard Daneman
Feb 15, 2018·Frontiers in Bioengineering and Biotechnology·Allison M BosworthEthan S Lippmann
Jun 6, 2019·Brain Structure & Function·Daniela López-EspíndolaAna Guadaño-Ferraz
Jul 25, 2019·Metabolic Brain Disease·Silvia MasnadaDavide Tonduti
Jun 2, 2020·Frontiers in Endocrinology·Pieter VancampSylvie Remaud
Jul 25, 2020·Scientific Reports·Hannah W SongEric V Shusta
Sep 1, 2017·Frontiers in Cellular Neuroscience·Soledad Bárez-López, Ana Guadaño-Ferraz
Oct 17, 2019·Biomicrofluidics·Seokyoung BangHong Nam Kim
Mar 18, 2020·Fluids and Barriers of the CNS·Aditya BhaleraoLuca Cucullo
Mar 8, 2020·Thyroid : Official Journal of the American Thyroid Association·Nina-Maria WilpertHeike Biebermann
Apr 24, 2020·Fluids and Barriers of the CNS·Michael J Workman, Clive N Svendsen
Sep 29, 2020·Frontiers in Neuroscience·Pieter VancampSylvie Remaud
Feb 6, 2019·Fluids and Barriers of the CNS·Richard F KeepLester R Drewes
Apr 2, 2020·Fluids and Barriers of the CNS·Michelle A EricksonWilliam A Banks
Jul 31, 2019·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Godwin DogbeviaMarkus Schwaninger
May 16, 2020·Frontiers in Neuroscience·Carmen Grijota-MartínezAna Guadaño-Ferraz
Jul 30, 2020·Journal of the Endocrine Society·Stefan GroenewegW Edward Visser
Sep 22, 2020·Current Protocols in Stem Cell Biology·Antje Appelt-MenzelOle Pless
Apr 26, 2018·Genes & Development·Natasha M O'BrownChenghua Gu
Dec 6, 2018·Fluids and Barriers of the CNS·Jackson G DeStefanoPeter C Searson
Sep 23, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Julia V GeorgievaEric V Shusta
Jun 24, 2020·Tissue Engineering. Part B, Reviews·Richard JeskeYan Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.